Implantable device therapy for epilepsy
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
44
NCT00391755
A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches
Phase: Phase 4
Role: Lead Sponsor
Start: Oct 31, 2006
Completion: Oct 31, 2009
NCT06424977
Biomarker Targeted Stimulation for Epileptiform Events
Phase: N/A
Start: Sep 1, 2025
Completion: Sep 1, 2029
Loading map...